RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of EVOK
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Evoke Pharma stock price on Tuesday which ended trading at $0.508
(Updated on Jul 02, 2024)

Buy candidate since Jul 02, 2024 PDF

The Evoke Pharma stock price gained 7.72% on the last trading day (Tuesday, 2nd Jul 2024), rising from $0.472 to $0.508. During the last trading day the stock fluctuated 18.00% from a day low at $0.500 to a day high of $0.590. The price has been going up and down for this period, and there has been a -3.79% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 46 thousand more shares were traded than the day before. In total, 70 thousand shares were bought and sold for approximately $35.67 thousand.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Evoke Pharma stock with a 90% probability to be traded between $0.440 and $0.619 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

EVOK Signals & Forecast

The Evoke Pharma stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $0.516. On a fall, the stock will find some support from the long-term average at approximately $0.501. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Monday, July 01, 2024, and so far it has risen 7.72%. Further rise is indicated until a new top pivot has been found. Evoke Pharma has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Evoke Pharma stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.470 and $0.465. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Evoke Pharma finds support just below today's level at $0.470. If this is broken, then the next support from accumulated volume will be at $0.465 and $0.451.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0900 between high and low, or 18.00%. For the last week, the stock has had daily average volatility of 11.71%.

Our recommended stop-loss: $0.487 (-4.12%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 7 days ago.)

Trading Expectations (EVOK) For The Upcoming Trading Day Of Wednesday 3rd

For the upcoming trading day on Wednesday, 3rd we expect Evoke Pharma to open at $0.533, and during the day (based on 14 day Average True Range), to move between $0.437 and $0.579, which gives a possible trading interval of +/-$0.0707 (+/-13.92%) up or down from last closing price. If Evoke Pharma takes out the full calculated possible swing range there will be an estimated 27.84% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.528 (3.94%) than the support at $0.470 (7.52%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Evoke Pharma stock A Buy?

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Evoke Pharma stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 1.983 Buy Candidate Upgraded

Predicted Opening Price for Evoke Pharma of Wednesday, July 3, 2024

Fair opening price July 3, 2024 Current price
$0.533 ( 4.83%) $0.508

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for EVOK

Fibonacci Support & Resistance Levels

Level Price
R3 0.623 22.54%
R2 0.588 15.77%
R1 0.567 11.59%
Price 0.508
S1 0.498 -1.94%
S2 0.477 -6.12%
S3 0.443 -12.88%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.610 20.03%
R2 0.560 10.19%
R1 0.528 3.94%
Price 0.508
S1 0.470 -7.52%
S2 0.465 -8.50%
S3 0.451 -11.26%

FAQ

What is the symbol for Evoke Pharma Stock and on which exchange is it traded?
The symbol for Evoke Pharma is EVOK and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Evoke Pharma Stock?
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Evoke Pharma stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

How to buy Evoke Pharma Stock?
Evoke Pharma Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Evoke Pharma Stock.

What's the current price of Evoke Pharma Stock?
As of the end of day on the Jul 02, 2024, the price of an Evoke Pharma (EVOK) share was $0.508.

What is the 52-week high and low for Evoke Pharma Stock?
The 52-week high for Evoke Pharma Stock is $1.79 and the 52-week low is $0.400.

What is the market capitalization of Evoke Pharma Stock?
As of the Jul 02, 2024, the market capitalization of Evoke Pharma is 4.056M.

When is the next earnings date for Evoke Pharma?
The upcoming earnings date for Evoke Pharma is Aug 08, 2024.
Click to get the best stock tips daily for free!

About Evoke Pharma

Evoke Pharma Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine ... EVOK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT